2002 Clinical Trials Collective 
Cannabis Law Report
JULY 9, 2021
Collectively, private investors have poured billions of dollars into these companies, with more money coming from non-profit organizations. Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way.
Cannabis Law Report
JUNE 10, 2021
An alternative approach to study relationships between marijuana policies and driving after marijuana use is to use surveys that collect information on self-reported behaviors and attitudes. Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Pediatr. 2017;171:142–9. JAMA Psychiat.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
NOVEMBER 24, 2021
Its use in China, Tibet, India, Nepal, Japan (McPartland and Hegman 2018 , Touw 1981 ), Ancient Greece and Rome (Butrica 2002 ), and Iran, Iraq, Turkey, Syria, and the Balkans (McPartland and Hegman 2018 ; Lozano 1997 ; Aldrich 1997 ) goes back thousands of years. Data collection. Bonini et al. Monique Lewis & John Flood.
The Cannigma
DECEMBER 12, 2022
Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. Current clinical trials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder. As such, there have been numerous clinical trials using ketamine. A typical dose is 150-500 mcg.
Expert insights. Personalized for you.
Let's personalize your content